Birchview Capital, LP 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Birchview Capital, LP disclosed 68 US equity positions worth $115.2m in its Q1 2025 13F filing. The largest position was BMY at 36.3% of the reported book, followed by CORT and ACAD. Against the Q4 2024 filing, it opened 3 new positions, added to 10 and reduced 10 among the top 50 holdings.
What did Birchview Capital, LP own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 36.3% | $41.8m | 685,192 | 0% | held |
| 2 | CORT CORCEPT THERAPEUTICS INC | Healthcare | 6.5% | $7.5m | 66,000 | -11% | reduced |
| 3 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 3.8% | $4.4m | 263,400 | -22% | reduced |
| 4 | PROTHENA CORP PLC | 3.6% | $4.1m | 332,974 | 9% | added | |
| 5 | BDSX BIODESIX INC | 3.1% | $3.6m | 5,736,113 | 0% | held | |
| 6 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.9% | $3.3m | 30,240 | 0% | held |
| 7 | ELUT ELUTIA INC | 2.6% | $3.0m | 1,187,735 | -3% | reduced | |
| 8 | AXGN AXOGEN INC | Healthcare | 2.6% | $3.0m | 161,000 | -18% | reduced |
| 9 | PHR PHREESIA INC | Healthcare | 2.5% | $2.9m | 114,700 | 0% | held |
| 10 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 2.1% | $2.5m | 138,000 | -7% | reduced |
| 11 | QDELUSD QUIDELORTHO CORP | 2.1% | $2.4m | 67,619 | 0% | held | |
| 12 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 2.0% | $2.3m | 48,002 | 0% | held |
| 13 | UTHR UNITED THERAPEUTICS CORP | Healthcare | 2.0% | $2.3m | 7,500 | -25% | reduced |
| 14 | DCGO DOCGO INC | 2.0% | $2.3m | 864,062 | 13% | added | |
| 15 | OVV OVINTIV INC | Energy | 1.9% | $2.2m | 52,200 | 0% | held |
| 16 | HROW HARROW HEALTH INC | 1.7% | $1.9m | 72,910 | 0% | held | |
| 17 | MASI* MASIMO CORP | 1.6% | $1.9m | 11,280 | -26% | reduced | |
| 18 | EQT EQT CORPORATION | Energy | 1.6% | $1.8m | 34,619 | 0% | held |
| 19 | CSTL CASTLE BIOSCIENCES INC | Healthcare | 1.5% | $1.8m | 88,404 | 13% | added |
| 20 | ALKS ALKERMES PLC | Healthcare | 1.4% | $1.7m | 50,000 | 0% | held |
| 21 | STOK STOKE THERAPEUTICS INC | Healthcare | 1.2% | $1.4m | 210,005 | 0% | held |
| 22 | TMCI TREACE MEDICAL CONCEPTS INC | Healthcare | 1.2% | $1.4m | 164,947 | 2% | added |
| 23 | FHTX FOGHORN THERAPEUTICS INC | Healthcare | 1.0% | $1.1m | 310,930 | 0% | held |
| 24 | QURE UNIQURE NV | 0.8% | $940.2k | 88,697 | 343% | added | |
| 25 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.7% | $773.2k | 67,002 | 0% | held | |
| 26 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.6% | $704.5k | 21,000 | 110% | added |
| 27 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 0.6% | $699.8k | 6,000 | 50% | added |
| 28 | KINIKSA PHARMACEUTICALS LTD | 0.6% | $666.4k | 30,006 | 0% | held | |
| 29 | HALO HALOZYME THERAPEUTICS INC | Healthcare | 0.6% | $638.1k | 10,000 | 0% | held |
| 30 | RARE ULTRAGENYX PHARMACEUTICAL INC | Healthcare | 0.5% | $579.4k | 16,000 | 0% | held |
| 31 | NVCR NOVOCURE LTD | Healthcare | 0.5% | $552.4k | 31,000 | 0% | held |
| 32 | SRRK SCHOLAR ROCK HOLDING CORP | Healthcare | 0.4% | $514.4k | 16,000 | 100% | added |
| 33 | KIDS ORTHOPEDIATRICS CORP | Healthcare | 0.4% | $492.6k | 20,000 | – | new |
| 34 | SLDB SOLID BIOSCIENCES INC | Healthcare | 0.4% | $476.4k | 128,768 | – | new |
| 35 | INBX INHIBRX BIOSCIENCES INC | 0.4% | $449.2k | 32,110 | 0% | held | |
| 36 | TXG 10X GENOMICS INC | Healthcare | 0.4% | $436.5k | 50,000 | 0% | held |
| 37 | CYTK CYTOKINETICS INC | Healthcare | 0.3% | $401.9k | 10,000 | 0% | held |
| 38 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 0.3% | $365.4k | 8,280 | -17% | reduced | |
| 39 | LUNG PULMONX CORP | Healthcare | 0.3% | $343.2k | 51,000 | 0% | held |
| 40 | CADL CANDEL THERAPEUTICS INC | 0.3% | $339.0k | 60,000 | 0% | held | |
| 41 | ATEC ALPHATEC HOLDINGS INC | Healthcare | 0.3% | $334.6k | 33,000 | -43% | reduced |
| 42 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 0.3% | $325.6k | 40,300 | 1% | added |
| 43 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 0.3% | $312.6k | 8,000 | 100% | added |
| 44 | APLSUSD APELLIS PHARMACEUTICALS INC | 0.3% | $306.2k | 14,000 | 0% | held | |
| 45 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.3% | $300.0k | 40,000 | 0% | held |
| 46 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.3% | $298.9k | 8,000 | – | new |
| 47 | XNCR XENCOR INC | Healthcare | 0.2% | $276.6k | 26,000 | 0% | held |
| 48 | OMGBP OUTSET MEDICAL INC | 0.2% | $271.9k | 24,584 | -93% | reduced | |
| 49 | 2655787D BLUEPRINT MEDICINES CORP | 0.2% | $239.0k | 2,700 | 0% | held | |
| 50 | AM6 AMICUS THERAPEUTICS INC | 0.2% | $228.5k | 28,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.